RBC Capital Markets adjusted its stance on CF Industries Holdings Inc. (NYSE:CF), downgrading the stock from 'Outperform' to 'Sector Perform' and setting a price target of $100. The firm cited the stock's approach to full valuation and potential near-term challenges as the primary reasons for the downgrade.

Helima Croft, global head of commodity strategy at RBC Capital Markets, and Fred Kempe, president and CEO of Atlantic Council, join CNBC's 'Power Lunch' to discuss geopolitics, the impact on energy, and more.

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within the bank. Through summer jobs and co-op placements, as well as internships, they gain practical work experience and learn about RBC’s extensive career opportunities.

RBC Capital analyst Michael Harvey maintained a Hold rating on Headwater Exploration (CDDRF – Research Report) yesterday and set a price target

RBC Capital Markets has upgraded the Utilities sector to Overweight, naming it the top defensive sector, while downgrading Energy to Market Weight. The decision follows a survey of RBCs US analysts, which

RBC Capital analyst Darko Mihelic maintained a Buy rating on Manulife Financial (MFC – Research Report) yesterday and set a price target of

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, National Bank economist Warren Lovely noted the important fact that global interest in Canadian bonds remains high,

APi Group (APG) upgraded to Outperform by RBC Capital Markets analysts, poised for gains amid electrification trends.

Investing.com -- RBC Capital Markets has downgraded both Anglo American (JO: AGLJ) plc and Antofagasta (LON: ANTO) plc to "underperform," citing valuation concerns, rising financial pressures, and challenges in key projects against a backdrop of heightened market risks.

A small change in BBVA’s takeover offer for Banco Sabadell SA announced Thursday seems to be a correction of a previous oversight, rather than an effort to make it easier for the Spanish bank to clear any hurdles,

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on the stock to $132 from the previous $108.

In a report released on January 15, Nik Modi from RBC Capital maintained a Buy rating on Kimberly Clark (KMB – Research Report), with a price